Margot Chima Selected Research

secukinumab

3/2023	Secukinumab responses vary across the spectrum of congenital ichthyosis in adults.
1/2021	Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margot Chima Research Topics

Disease

4	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2020 - 09/2018
3	Alopecia Areata 10/2022 - 01/2019
3	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2019
2	Infections 03/2023 - 11/2020
2	Ichthyosis (Xeroderma) 03/2023 - 10/2022
2	Alopecia (Baldness) 10/2022 - 01/2022
1	Mycoses (Diseases, Fungus) 03/2023
1	Familial Perifolliculitis Capitis Abscedens Et Suffodiens 03/2022
1	Erythema 11/2020
1	Cicatrix (Scar) 11/2020
1	Dermatitis 11/2020
1	Acneiform Eruptions 11/2020
1	Skin Diseases (Skin Disease) 01/2019
1	Vitiligo 01/2019
1	Inflammation (Inflammations) 09/2018

Drug/Important Bio-Agent (IBA)

4	Interleukin-17 (Interleukin 17)IBA 03/2023 - 01/2019
2	secukinumabIBA 03/2023 - 01/2021
2	SaltsIBA 10/2022 - 01/2022
2	dupilumabIBA 10/2022 - 01/2022
2	CytokinesIBA 01/2019 - 09/2018
1	Antimicrobial PeptidesIBA 10/2022
1	risankizumabIBA 03/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Ointments (Pastes)IBA 02/2020
1	Phosphodiesterase 4 InhibitorsIBA 02/2020
1	crisaboroleIBA 02/2020
1	Interleukin-22 (IL-22)IBA 01/2019
1	6-sulfo sialyl Lewis XIBA 01/2019
1	brodalumabIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Interleukin-9 (Interleukin 9)IBA 01/2019
1	Interleukin-13IBA 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 09/2018
1	Adalimumab (Humira)FDA Link 09/2018
1	Etanercept (Enbrel)FDA Link 09/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018
1	Infliximab (Remicade)FDA Link 09/2018

Therapy/Procedure

1	Aftercare (After-Treatment) 10/2022
1	Lasers (Laser) 11/2020
1	Therapeutics 01/2019